Mirikizumab

Treatment for: Ulcerative Colitis U.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab INDIANAPOLIS, April 13, 2023 /PRNewswire/ […]

Read more

FDA Approves Epkinly

FDA Approves Epkinly (epcoritamab-bysp) Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) NORTH […]

FDA Approves Uzedy

FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults PARSIPPANY, N.J., TEL AVIV & PARIS, […]

FDA Approves RizaFilm

FDA Approves RizaFilm (rizatriptan) Oral Film for the Treatment of Acute Migraine SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) […]